- Home
- DALN vs KAPA Comparison
DALN vs KAPA Comparison
Compare DALN & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DALN
- KAPA
- Stock Information
- Founded
- DALN 1954
- KAPA 2013
- Country
- DALN United States
- KAPA United States
- Employees
- DALN N/A
- KAPA N/A
- Industry
- DALN Newspapers/Magazines
- KAPA
- Sector
- DALN Consumer Discretionary
- KAPA
- Exchange
- DALN Nasdaq
- KAPA NYSE
- Market Cap
- DALN 24.6M
- KAPA 19.9M
- IPO Year
- DALN 2008
- KAPA 2024
- Fundamental
- Price
- DALN $6.70
- KAPA $1.63
- Analyst Decision
- DALN
- KAPA Strong Buy
- Analyst Count
- DALN 0
- KAPA 1
- Target Price
- DALN N/A
- KAPA $9.00
- AVG Volume (30 Days)
- DALN 52.2K
- KAPA 6.1M
- Earning Date
- DALN 03-05-2025
- KAPA 02-23-2025
- Dividend Yield
- DALN 2.39%
- KAPA N/A
- EPS Growth
- DALN N/A
- KAPA N/A
- EPS
- DALN N/A
- KAPA N/A
- Revenue
- DALN $128,286,000.00
- KAPA N/A
- Revenue This Year
- DALN N/A
- KAPA N/A
- Revenue Next Year
- DALN N/A
- KAPA N/A
- P/E Ratio
- DALN N/A
- KAPA N/A
- Revenue Growth
- DALN N/A
- KAPA N/A
- 52 Week Low
- DALN $2.98
- KAPA $0.85
- 52 Week High
- DALN $7.86
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- DALN 49.01
- KAPA N/A
- Support Level
- DALN $6.75
- KAPA N/A
- Resistance Level
- DALN $7.19
- KAPA N/A
- Average True Range (ATR)
- DALN 0.32
- KAPA 0.00
- MACD
- DALN -0.13
- KAPA 0.00
- Stochastic Oscillator
- DALN 0.00
- KAPA 0.00
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.